Search engine for other government resources

Rabeprazole MedlinePlus Drug Information

Rabeprazole is used to treat ulcers (sores in the lining of the stomach or intestine) and is used in combination with other medications to eliminate ...
medlineplus.gov/druginfo/meds/a699060.html

Rabeprazole C18H21N3O3S - PubChem

Rabeprazole is an alpha-pyridylmethylsulfinyl benzimidazole and a selective and irreversible proton pump inhibitor with antisecretory property. Rabepr ...
pubchem.ncbi.nlm.nih.gov/compound/rabeprazole

Rabeprazole the role of proton pump inhibitors in ...

Rabeprazole (Pariet) is a substituted benzimidazole proton pump inhibitor with potent gastric acid suppression properties. Its high acid-base ...
pubmed.ncbi.nlm.nih.gov/16307499/

Ascend Laboratories LLC RABEPRAZOLE SODIUM - rabeprazole ...

Rabeprazole sodium delayed-release tablets, in combination with amoxicillin and clarithromycin as a three drug regimen, are indicated for the ...
dailymed.nlm.nih.gov/dailymed/getFile.cfm?setid=45092108-7c4a-48f9-8222-ca8612e82189

Rabeprazole pharmacokinetics and pharmacokinetic drug ...

Rabeprazole is the most recently approved proton pump inhibitor in Germany. The substance has an absolute bioavailability upon oral administration of ...
pubmed.ncbi.nlm.nih.gov/12369444/

Rabeprazole a review of its use in acid-related ...

Rabeprazole is an inhibitor of the gastric proton pump. It causes dose-dependent inhibition of acid secretion and has a more rapid onset of action ...
pubmed.ncbi.nlm.nih.gov/10551440/

PDF Aciphex rabeprazole sodium - Food and Drug Administration

Rabeprazole sodium is a white to slightly yellowish-white solid. It is very soluble in water and methanol, freely soluble in ethanol, chloroform and ...
www.accessdata.fda.gov/drugsatfda_docs/label/1999/20973lbl.pdf

Pharmacokinetics of rabeprazole following single ...

The study was designed to determine the absolute bioavailability of 20 mg rabeprazole tablets in normal, healthy subjects in comparison with ...
pubmed.ncbi.nlm.nih.gov/15704613/

Review article the pharmacokinetics of rabeprazole in ...

Rabeprazole, a newly developed proton pump inhibitor, has been shown to be effective for the treatment of gastric and duodenal ulcers and for ...
pubmed.ncbi.nlm.nih.gov/10491724/

CYP2C19 Genotype and the PPIs--focus on Rabeprazole - PubMed

Rabeprazole is therefore the PPI least affected by CYP4502C19 genetic polymorphism. This unique feature of rabeprazole complements rabeprazole's fast ...
pubmed.ncbi.nlm.nih.gov/16359346/

Rabeprazole sodium C18H20N3NaO3S - PubChem

Rabeprazole Sodium is the sodium salt of the prodrug rabeprazole, a substituted benzimidazole proton pump inhibitor, with potential anti-ulcer ...
pubchem.ncbi.nlm.nih.gov/compound/Rabeprazole-sodium

PDF rabeprazole sodium Delayed-Release Tablets

Rabeprazole sodium is a white to slightly yellowish-white solid. It is very soluble in water and methanol, freely soluble in ethanol, chloroform and ...
www.accessdata.fda.gov/drugsatfda_docs/label/2002/20973S013lbl.pdf

Rabeprazol MedlinePlus medicinas

Rabeprazol se usa para tratar los sntomas de enfermedad por reflujo gastroesofgico (GERDuna condicin en la que el flujo en direccin opuesta del ...
medlineplus.gov/spanish/druginfo/meds/a699060-es.html

Rabeprazole sodium monohydrate C18H22N3NaO4S - PubChem

Rabeprazole sodium monohydrate. SCHEMBL838857. 1033853-22-3. 1H-Benzimidazole, 2-(((4-(3-methoxypropoxy)-3-methyl-2-pyridinyl)methyl)sulfinyl)- ...
pubchem.ncbi.nlm.nih.gov/compound/Rabeprazole-sodium-monohydrate

Combination Therapy of High-Dose Rabeprazole Plus ...

Background: In recent years, proton pump inhibitors (PPIs) have been investigated at high-dose to modulate tumor microenvironment acidification thus ...
pubmed.ncbi.nlm.nih.gov/33105819/

Rabeprazole-based eradication therapy for Helicobacter ...

Rabeprazole-based therapies achieved 50% eradication of clarithromycin-resistant H. pylori, and even achieved good rates in extensive metabolizers ...
pubmed.ncbi.nlm.nih.gov/17439512/

Rabeprazole By mouth - National Library of Medicine ...

Rabeprazole is used to treat duodenal ulcers, gastroesophageal reflux disease (GERD), and Zollinger-Ellison syndrome. It may also be used together ...
www.ncbi.nlm.nih.gov/pubmedhealth/PMHT0011923/?report=details

PDF Reference ID 3675792

Rabeprazole has been shown to inhibit cyclosporine metabolism . in vitro (7.3). ACIPHEX inhibits gastric acid secretion and may interfere with the ...
www.accessdata.fda.gov/drugsatfda_docs/label/2014/020973s035204736s005lbl.pdf

DailyMed - RABEPRAZOLE SODIUM tablet delayed release

Rabeprazole Sodium delayed-release tablets is a proton pump inhibitor (PPI) indicated in adults for: Healing of Erosive or Ulcerative Gastroesophageal ...
dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0e2e00fa-c4c5-4de7-adf9-cd9786b97016&version=2

Rabeprazole Sulfone C18H21N3O4S - PubChem

Rabeprazole Sulfone. 117976-47-3. UNII-I2E100O20P. 2-[[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methylsulfonyl]-1H-benzimidazole. I2E100O20P
pubchem.ncbi.nlm.nih.gov/compound/Rabeprazole-Sulfone